Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Apr;20(2):169-76.
doi: 10.3346/jkms.2005.20.2.169.

Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course

Jin-Hong Yoo  1 , Dong-Gun Lee, Su Mi Choi, Jung-Hyun Choi, Wan-Shik Shin, Myungshin Kim, Dongeun Yong, Kyungwon Lee, Woo-Sung Min, Chun-Choo Kim
Affiliations

Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course

Jin-Hong Yoo et al. J Korean Med Sci. 2005 Apr.

Abstract

An increase in vancomycin-resistant enterococcal (VRE) bacteremia in hemato-oncological patients (n=19) in our institution from 2000 through 2001 led us to analyze the molecular epidemiologic patterns and clinical features unique to our cases. The pulsed field gel electrophoresis of the isolates revealed that the bacteremia was not originated from a single clone but rather showed endemic pattern of diverse clones with small clusters. A different DNA pattern of blood and stool isolates from one patient suggested exogenous rather than endogenous route of infection. Enterococcus faecium carrying vanA gene was the causative pathogen in all cases. Patients with VRE bacteremia showed similar clinical courses compared with those with vancomycin-susceptible enterococcal (VSE) bacteremia. Vancomycin resistance did not seem to be a poor prognostic factor because of similar mortality (5/8, 62.5%) noted in VSE bacteremia. Initial disease severity and neutropenic status may be major determinants of prognosis in patients with VRE bacteraemia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Summary of monthly occurrence of vancomycin-resistant Enterococcus (VRE) bacteremia from January 2000 to December 2001.
Fig. 2
Fig. 2
Pulsed field gel electrophoresis (PFGE) of isolates from patients with VRE. 1-14, case numbers; A-J, PFGE genotypes (See Table I).
Fig. 3
Fig. 3
PFGE analysis of VRE isolates from bacteremic patients and from non-bacteremic (NB) patients. M, molecular weight markers; lane 1-14: blood isolates from bacteremic patients (see Table I and Fig. 2); lane 15: blood isolate identical with that of lane 13; lane 16: stool isolates from the same person as lane 13; lanes 17-31: isolates from NB patients; lanes 17 & 18: urine and stool isolates from patient NB1, respectively; lanes 19 & 20: patient NB2; lanes 21 & 22: patient NB3; lanes 23 & 24: patient NB4; lanes 25 & 26: patient NB5; lanes 27 & 28: patient NB6; lanes 29 & 30: patient NB7; lane 31: urine isolate from patient NB8. Lines connecting lanes 7 and 31, lanes 9 and 30, lanes 12 and 21-22 indicate clonally related pairs and groups.
Fig. 4
Fig. 4
Summary of epidemiological patterns of four main clones (B, C, E, F) circulating in our institution during 2 yr (2000-2001).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686–707. - PMC - PubMed
    1. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med. 2001;135:484–492. - PubMed
    1. Lee K, Jang SJ, Lee HJ, Ryoo N, Kim M, Hong SG, Chong Y The Korean Nationwide Surveillance of Antimicrobial Resistance Group. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001. J Korean Med Sci. 2004;19:8–14. - PMC - PubMed
    1. Lee K, Lee HS, Jang SJ, Park AJ, Lee MH, Song WK, Chong Y Members of Korean Nationwide Surveillance of Antimicrobial Resistance Group. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and Gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci. 2001;16:262–270. - PMC - PubMed
    1. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol. 2001;39:1165–1168. - PMC - PubMed